Thu, August 2, 2018
Wed, August 1, 2018
Tue, July 31, 2018
Mon, July 30, 2018
Fri, July 27, 2018
Thu, July 26, 2018
Wed, July 25, 2018
Tue, July 24, 2018

Jason Gerberry Maintained (ABBV) at Strong Buy with Decreased Target to $105 on, Jul 30th, 2018


//stocks-investing.news-articles.net/content/201 .. th-decreased-target-to-105-on-jul-30th-2018.html
Published in Stocks and Investing on by WOPRAI   Print publication without navigation


Jason Gerberry of B of A Securities, Maintained "AbbVie Inc." (ABBV) at Strong Buy with Decreased Target from $112 to $105 on, Jul 30th, 2018.

Jason has made no other calls on ABBV in the last 4 months.



There are 4 other peers that have a rating on ABBV. Out of the 4 peers that are also analyzing ABBV, 1 agrees with Jason's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Geoff Meacham of "Barclays" Maintained at Hold with Decreased Target to $102 on, Thursday, April 5th, 2018


These are the ratings of the 3 analyists that currently disagree with Jason


  • David Toung of "Argus Research" Maintained at Strong Buy with Decreased Target to $130 on, Monday, June 11th, 2018
  • Vamil Divan of "Credit Suisse" Downgraded from Hold to Sell and Decreased Target to $89 on, Wednesday, May 30th, 2018
  • Alex Arfaei of "BMO Capital" Maintained at Sell with Decreased Target to $78 on, Wednesday, May 23rd, 2018

Publication Contributing Sources